These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 25752526

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study.
    Pintér G, Batta G, Kéki S, Mándi A, Komáromi I, Takács-Novák K, Sztaricskai F, Röth E, Ostorházi E, Rozgonyi F, Naesens L, Herczegh P.
    J Med Chem; 2009 Oct 08; 52(19):6053-61. PubMed ID: 19791806
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of fluorescent ristocetin aglycon derivatives with remarkable antibacterial and antiviral activities.
    Sipos A, Máté G, Rőth E, Borbás A, Batta G, Bereczki I, Kéki S, Jóna I, Ostorházi E, Rozgonyi F, Vanderlinden E, Naesens L, Herczegh P.
    Eur J Med Chem; 2012 Dec 08; 58():361-7. PubMed ID: 23149298
    [Abstract] [Full Text] [Related]

  • 4. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS, Pavlov AY, Olsufyeva EN, Mirchink EP, Preobrazhenskaya MN.
    J Med Chem; 2003 Mar 27; 46(7):1204-9. PubMed ID: 12646030
    [Abstract] [Full Text] [Related]

  • 5. Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.
    Bereczki I, Kicsák M, Dobray L, Borbás A, Batta G, Kéki S, Nikodém ÉN, Ostorházi E, Rozgonyi F, Vanderlinden E, Naesens L, Herczegh P.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3251-4. PubMed ID: 24974341
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nano-sized clusters of a teicoplanin ψ-aglycon-fullerene conjugate. Synthesis, antibacterial activity and aggregation studies.
    Tollas S, Bereczki I, Sipos A, Rőth E, Batta G, Daróczi L, Kéki S, Ostorházi E, Rozgonyi F, Herczegh P.
    Eur J Med Chem; 2012 Aug 01; 54():943-8. PubMed ID: 22795664
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Chemical modification of glycopeptide antibiotics].
    Pavlov AIu, Preobrazhenskaia MN.
    Bioorg Khim; 1998 Sep 01; 24(9):644-62. PubMed ID: 9813730
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities.
    Sipos A, Török Z, Rőth E, Kiss-Szikszai A, Batta G, Bereczki I, Fejes Z, Borbás A, Ostorházi E, Rozgonyi F, Naesens L, Herczegh P.
    Bioorg Med Chem Lett; 2012 Dec 01; 22(23):7092-6. PubMed ID: 23099097
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and antibacterial activity of alkyl derivatives of the glycopeptide antibiotic A40926 and their amides.
    Maffioli SI, Ciabatti R, Romanò G, Marzorati E, Preobrazhenskaya M, Pavlov A.
    Bioorg Med Chem Lett; 2005 Aug 15; 15(16):3801-5. PubMed ID: 15993054
    [Abstract] [Full Text] [Related]

  • 12. Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.
    Szűcs Z, Kelemen V, Le Thai S, Csávás M, Rőth E, Batta G, Stevaert A, Vanderlinden E, Naesens L, Herczegh P, Borbás A.
    Eur J Med Chem; 2018 Sep 05; 157():1017-1030. PubMed ID: 30170320
    [Abstract] [Full Text] [Related]

  • 13. Mono and double modified teicoplanin aglycon derivatives on the amino acid no. 7; structure-activity relationship.
    Pavlov AY, Preobrazhenskaya MN, Malabarba A, Ciabatti R, Colombo L.
    J Antibiot (Tokyo); 1998 Jan 05; 51(1):73-8. PubMed ID: 9531990
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics].
    Olsuf'eva EN, Preobrazhenskaia MN.
    Bioorg Khim; 2006 Jan 05; 32(4):339-59. PubMed ID: 16909859
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin.
    Cheng M, Ziora ZM, Hansford KA, Blaskovich MA, Butler MS, Cooper MA.
    Org Biomol Chem; 2014 Apr 28; 12(16):2568-75. PubMed ID: 24608916
    [Abstract] [Full Text] [Related]

  • 19. Comparison and modeling study of vancomycin, ristocetin A, and teicoplanin for CE enantioseparations.
    Gasper MP, Berthod A, Nair UB, Armstrong DW.
    Anal Chem; 1996 Aug 01; 68(15):2501-14. PubMed ID: 8694258
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.